Skip links
Companies
› Poland › NCAGE THERAPEUTICS S.A.
Company registry profile
NCAGE THERAPEUTICS S.A. logo

NCAGE THERAPEUTICS S.A.

Join Stock Company Active

in

From the registry

Registration details

Registration No.
38487614000000
Incorporation Date
2024-07-25
Company Type
Join Stock Company
Address
KRAKÓW, Poland
Website
www.ncage.org/
Status
Active
Country
Poland
Source: National Court Register (KRS)Registry coverage
Registry summary

Company overview

NCAGE THERAPEUTICS S.A. is a Join Stock Company registered in Poland under 38487614000000, and its current status with National Court Register (KRS) is active. The company was incorporated on 25 July 2024 and lists its registered address as KRAKÓW, Poland. 2 shareholders are on record for NCAGE THERAPEUTICS S.A., including at least one natural person recorded as a direct holder; the filing carries no beneficial-ownership flag, so that holder is noted here as a recorded shareholder rather than a confirmed ultimate beneficial owner (UBO).

Data Provenance
This record is sourced directly from official government registries, including National Court Register (KRS).

View data sources →

We don’t stop at registry data.
Every company record is enriched with additional intelligence:
  • Company fundamentals
  • Corporate linkage & group structures
  • Digitized company financials
  • Firmographics — websites, social profiles, revenue and employee estimates

View full data dictionary →

Shareholders

2

Swipe or scroll for more columns

Shareholder Type Holding Source Document
Jonathan Heddle 55.8% National Court Register (KRS)

Registry notes and limitations

Two shareholders are currently on record for NCAGE THERAPEUTICS S.A., filed with National Court Register (KRS).

The largest of these is Jonathan Heddle, holding 55.8% — a majority holding — followed by Christopher Lewis Kaplan at 44.2%.

Every shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.

Officers

3

JB
John Bason ACTIVE

Residence
🇵🇱 Poland
Occupation
President Of The Management Board

CK
Christopher Kaplan ACTIVE

Residence
🇵🇱 Poland
Occupation
Vice President Of The Management Board

JH
Jonathan Heddle ACTIVE

Residence
🇵🇱 Poland
Occupation
Member Of The Management Board

Registry notes and limitations

Three officers are currently on record for NCAGE THERAPEUTICS S.A., filed with National Court Register (KRS). John Bason serves as President Of The Management Board; Christopher Kaplan serves as Vice President Of The Management Board; Jonathan Heddle serves as Member Of The Management Board.

Management authority at NCAGE THERAPEUTICS S.A. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

The source filing doesn't specify representation authority — whether officers can act individually or must sign jointly to bind the company — so that detail isn't available here.

Group Structure

Top of recorded group
NCAGE THERAPEUTICS S.A.
Poland
NCAGE LIMITED
United KingdomGB 16840115

How these relationships were recorded

NCAGE THERAPEUTICS S.A. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Each of these downward relationships is derived rather than filed: resolved by matching entities across the registry network, not stated directly in a single document.

Those 1 subsidiary spans Poland, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

Registry questions

Frequently asked questions

Who owns NCAGE THERAPEUTICS S.A.?

Two shareholders are currently on record for NCAGE THERAPEUTICS S.A., filed with National Court Register (KRS). The largest of these is Jonathan Heddle, holding 55.8% — a majority holding — followed by Christopher Lewis Kaplan at 44.2%. Every shareholder shown is an individual, recorded as a direct holder at this level; the record carries no UBO/PSC flag, so beneficial-owner status is not confirmed here.

Who is NCAGE THERAPEUTICS S.A.'s UBO (Ultimate Beneficial Owner)?

At least one shareholder recorded for NCAGE THERAPEUTICS S.A. is a natural person. The record carries no dedicated UBO/PSC flag, so that holder is stated here as a recorded shareholder rather than a confirmed Ultimate Beneficial Owner (UBO).

How many shareholders does NCAGE THERAPEUTICS S.A. have on record?

2 shareholders are shown on record for NCAGE THERAPEUTICS S.A..

What is NCAGE THERAPEUTICS S.A.'s company registration number?

NCAGE THERAPEUTICS S.A.'s registration number is 38487614000000, filed with National Court Register (KRS) in Poland. Its current status on the register is active.

Is NCAGE THERAPEUTICS S.A. still an active company?

NCAGE THERAPEUTICS S.A.'s status on National Court Register (KRS) is listed as active.

When was NCAGE THERAPEUTICS S.A. incorporated?

NCAGE THERAPEUTICS S.A. was incorporated on 25 July 2024, according to National Court Register (KRS).

What is NCAGE THERAPEUTICS S.A.'s registered address?

The registered address on file for NCAGE THERAPEUTICS S.A. is KRAKÓW, Poland.

What legal structure is NCAGE THERAPEUTICS S.A. registered as?

NCAGE THERAPEUTICS S.A. is registered as a Join Stock Company in Poland.

Who are the officers/directors of NCAGE THERAPEUTICS S.A.?

Three officers are currently on record for NCAGE THERAPEUTICS S.A., filed with National Court Register (KRS). John Bason serves as President Of The Management Board; Christopher Kaplan serves as Vice President Of The Management Board; Jonathan Heddle serves as Member Of The Management Board. Management authority at NCAGE THERAPEUTICS S.A. sits with these individuals, not with shareholders, who are covered separately and hold ownership rather than control.

Does NCAGE THERAPEUTICS S.A. have a parent company or subsidiaries?

NCAGE THERAPEUTICS S.A. has no recorded parent company — it sits at the top of its own group structure, with 1 subsidiary recorded beneath it across 2 jurisdictions. Those 1 subsidiary spans Poland, United Kingdom jurisdictions, though this list should not be read as complete — subsidiaries only become visible here where shareholder data has actually been filed with a register, so holdings in jurisdictions without that filing simply won't appear.

This website uses cookies to improve your web experience.